Cephamycin intermediate compound and preparation method thereof

The technology of a compound, cephamycin, is applied in the field of preparation of cephalosporin compounds, which can solve problems such as unfavorable long-term storage

Active Publication Date: 2013-07-10
山东安弘制药有限公司
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the carboxylic acid of this invention is an amorphous product, and its hygroscopicity is stronger, and its triethylamine salt has stronger hygroscopicity because of good water solubility, is unfavorable for long-term storage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cephamycin intermediate compound and preparation method thereof
  • Cephamycin intermediate compound and preparation method thereof
  • Cephamycin intermediate compound and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1, preparation of cephamycin intermediate formula (I) compound

[0032]Dissolve 0.1 mol of the prepared oil containing the compound of formula (II) in 330 ml of acetone, mix thoroughly and cool down to 5°C, slowly add 21.8 g (0.12 mol) of dicyclohexylamine dropwise under stirring, the feed solution It gradually becomes muddy. Keep warm at about 5°C to grow crystals for 2 hours, filter, wash the filter cake with 120ml of acetone, and drain. The obtained solid was vacuum-dried at 40°C until the water content was less than 1%, and 54.2 g of white crystalline powder was obtained, which was the compound of formula (I) of the cephamycin intermediate of the present invention. The yield was 87.9%, and the HPLC purity was 99.53%.

[0033] The structure of the obtained product was confirmed, and the results are as follows:

[0034] IR(KBr):.

[0035] Sample absorption peak / cm -1

vibration type

group

3153

ν N-H

-NH

2939，2858...

Embodiment 2

[0042] Add ethyl acetate to the prepared oil containing 0.1 mol of the compound of formula (II) to prepare an ethyl acetate solution with a concentration of about 100 g / L, cool down to 10°C, and dropwise add 21.8 g of dicyclohexylamine (0.12 mol), add 0.1g of seed crystals, grow the crystals for 3h, cool down to 0°C, continue to grow the crystals for 4h, filter, wash the filter cake with 200ml of ethyl acetate, and drain. The obtained solid was vacuum-dried at 40°C until the water content was less than 1%, and 57.4 g of off-white crystalline powder was obtained, which was the compound of formula (I) of the cephamycin intermediate of the present invention; the yield was 93.1%, and the HPLC purity was 99.27%.

Embodiment 3

[0044] Dissolve 0.1 mol of the oily substance containing the compound of formula (II) in 100 ml of N,N-dimethylformamide, cool down to 5°C, slowly add 21.8 g (0.12 mol) of dicyclohexylamine dropwise, Cultivate the crystal for 2 hours, filter, wash the filter cake with 100ml N,N-dimethylformamide, and drain it. The obtained solid was vacuum-dried at 40°C until the water content was less than 1%, and 53.9 g of white crystalline powder was obtained, which was the compound of formula (I) of the cephamycin intermediate of the present invention. The yield was 87.5%, and the purity of the product was 99.60% by HPLC.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a cephamycin intermediate compound and a preparation method thereof. The cephamycin intermediate compound has a structure of formula (I), and is prepared by directly reacting 7beta-chloroacetamide-7alpha-methoxy-3-(1-methyl-1H-tetrazole-5-thiomethyl)-3-cephem-4-carboxylic acid and dicyclohexylamine in a specific solvent to form a salt and crystallizing. The cephamycin intermediate compound has the characteristics of high purity, high stability and the like, is conductive to improving the purity of cephamycin final products such as cefminox sodium, cefmetazole sodium and cefotetan disodium, and is beneficial to large-scale production and application.

Description

technical field [0001] The invention belongs to the technical field of preparation of cephalosporin compounds in the pharmaceutical synthesis technology, and in particular relates to a cephamycin intermediate compound and a preparation method thereof. Background of the invention [0002] Cephamycin can be considered as an important branch of cephalosporins. There is a trans-methoxy group at the C7 position on the β-lactam ring, which makes this class of antibiotics have strong resistance to β-lactamase. Common anaerobic bacteria that are prone to producing β-lactamase, such as Bacteroides fragilis (Bf), have strong antibacterial properties, which is precisely the shortcoming of common cephalosporins. [0003] Common cefamycins currently on the global market include cefminox sodium, cefmetazole sodium, cefotetan disodium and cefoxitin sodium, etc., wherein only cefminox sodium is in crystalline form, and the others are generally non-crystalline; in addition, At present, ceph...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D501/04C07D501/57C07C211/35C07C209/00
Inventor 汤沸符淙淙赵卫良王勇进
Owner 山东安弘制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap